| Name | Title | Contact Details |
|---|
As a company, we believe in digital health for everyone everywhere. We have created a new category of therapeutic product – the digital health feedback system – to allow people of all ages and cultures to power their own health, taking better care of themselves and each other. We see two trends: First, there are more people with mobile phones than there are with access to clean, running water. Second, chronic, often lifestyle-related diseases like diabetes are the world’s biggest healthcare problem, and our health systems can’t cope because they are optimized to treat the acute conditions prevalent decades ago. Our vision is to integrate medicines that treat chronic conditions with mobile technology – via our ingestible sensor – to make healthcare more accessible, manageable and innovative. We believe that by providing the right technology to individuals who deliver and receive healthcare, we can build a more effective healthcare system with new care paradigms focused on daily care and new information-based business models.
Century Care Ctr is a Century, FL-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
obé is a premium fitness network and community that gets you results AND brings the fun. With 22 live classes per day and 5,000+ on-demand workouts available 24/7—all taught by the best instructors in NYC—our motto is: get fit, not bored. From HIIT to Pilates to Dance, Sculpt, Strength, Yoga, Pre/Postnatal, Cardio Boxing, and more, obé classes are designed to meet you wherever you are in your fitness journey.
Uniform Data System for Medical Rehabilitation is one of the leading providers in Healthcare, Pharmaceuticals, and Biotech. It is based in Buffalo, NY. To find more information about Uniform Data System for Medical Rehabilitation, please visit www.udsmr.org
We are a late stage biopharmaceutical company focused on the development and commercialization of serlopitant for the treatment of pruritus, or itch, associated with various conditions. We believe that serlopitant, a highly selective small molecule inhibitor of the neurokinin 1 receptor, or NK1R, given as a once daily, oral tablet, has the potential to significantly alleviate pruritus associated with various conditions.